Wheeler Bio
Life Sciences
Wheeler Bio brings biologics drug innovators, discovery CROs, and CDMOs together to solve an outdated industry bottleneck and shorten the time to market for new drugs with a unique partnering model built on shared success and lasting collaborations.
Why we invested:
Market Need
Bringing life-changing new drugs to market in a timely and affordable manner has never been more challenging or important. Too often, innovators and their outsourcing providers have competing timeline horizons, budget expectations, and business priorities that fail to fully consider all chemistry, manufacturing and control aspects until it is too late. This can result in delayed investigational new drug submissions or clinical hold letters from the FDA.
-
"We could not be more pleased to have Boyd Street Ventures as an investor. Their management team and Strategic Advisory Board can be a great source of insight, particularly in the areas of strategy and operations, and they are actively engaged in the honing for success."
Jesse McCool Co-Founder & CEO, Wheeler Bio -
"James has been extremely helpful in making important introductions for us. I appreciate the fact that he’s always asking me about our plans to grow even faster, and it seems that every time I talk to him he has another great idea for a potential new customer."
Nathan Den Herder Founder & CEO, Ardley